Ethnographic approach to design knowledge. Dialogue and participation as discovery tools within complex knowledge contexts

The following paper explores two main concepts: a) the ethnography as a thick and qualitative observation method, which refers to an active interpretation of the traditional ethnography by the communication design research mindset; b) the definition of design knowledge space, as extended boundaries for the physical place of design activities. In the paper we introduce the interpretation of ethnographic plan as a tool for communication epistemology and as a relevant research tool for the understanding and interaction with high complexity knowledge contexts. Ethnography has been practiced within design organizations aiming to provide remarks and insights about knowledge management systems within knowledge intensive organizations. We describe ethnography structure, tools, data analysis and interpretation techniques. For communication design practice, the field research is not considered merely as a techniques toolbox that have been borrowed from social sciences; design rhetoric refers to the major purpose of design thinking to act transformations in the observed contexts; ethnography is a way to face problem setting through research tools that consider observation and dialogue as the necessary design premise

Network Shapes Design Activities. ICT Supporting Open and Shared Design Processes

The network paradigm refers to individuals as being continually involved in processes of sharing and being able to organize into creative communities of practice and knowledge. Some of these communities are developing and act creatively in the digital spaces of the net. They explore and push forward the ICT technology boundaries: everyday we observe on the Internet flourishing sources and authorities, new ways to organize information and public heritage worked out by different people and organizations that show much more richness everyday and become more and more interesting. Current researches on “creativity support tools” investigate the creative process as situated cognition activity in physical and technological spaces made up of tools such as creativity labs for innovation and frameworks for knowledge intensive activities. (E.g. L3D lab in Chicago, Fraunhofer Institutes in Germany). Research is revealing that creativity spaces should be differently designed for each creative action, which manages a particular kind of knowledge and needs to be supported by specific tools. Design activity is linked to the design space in which it occurs. It is a knowledge transfer process based on tools, from pencil to cognitive maps: knowledge comes steadily into shape until it becomes a designed artifact. It is a creative and cooperative action itself, presenting the same attributes as network communities. The ongoing research is hosted at Politeca, a Design Knowledge Centre at Politecnico di Milano focusing on network tools placed into design spaces, exploring which kind of support they can provide in design processes. The aim of research is to verify the need and test the use of tools in design contexts by two different design communities: the design student community (in faculty labs and courses) and the practitioner community (knowledge at work in different design teams). The paper describes the first phase of experiments. We study design activities “in situ” through participant observation methods derived from ethno methodology; we are creating a sort of “designers’ observatory” from which we will able to explore design processes from the point of view of both designers and researchers. In order to turn research findings into actions, forthcoming phases will verify emerging needs of knowledge by allowing designers to try out their work directly with a series of ICT design tools, and then providing for them a custom framework of tools to use. Network tools are technology to act on and experience knowledge, consistently with our ideas that sharing heightens knowledge and that design activity involves sharing expertise. Proceeding from this, we aim to shape toolkits for design activities in order to enhance creative sharing and to contribute to the development of a knowledge base for design made up of a dialogue between resources and experiences

Non-parametric estimation of survival probabilities with a time-dependent exposure switch: application to (simulated) heart transplant data

Background: To summarize the survival experience of patients waiting for heart transplant and to compare it with the post-transplant survival it is not possible to use the Kaplan-Meier estimator considering the intervention status as fixed in time because of the well known "immortaltime bias" issue.Methods: We reviewed and applied to a simulated dataset the available methods to perform a non-parametric analysis accounting for the time-varying nature of the transplant status. Specifically we considered the Simon-Makuch estimator and the recently proposed "clock-back" estimator.Results: We showed that the Simon-Makuch estimator for the survival of patients on list is unbiased but the corresponding estimator of the post-transplant survival is not reliable for non-markov contexts like the one considered. Instead, if the semi-Markov assumption could be postulated (the post-transplant mortality depends mainly on the time since transplant and not on the waiting time to the intervention), the "clock-back" estimator produces valid results.Conclusion: We enlightened the importance of testing the process memory assumptions (e.g. Markov properties) in order to choose the approach more reliable. Moreover, we recommend the use of the Simon-Makuch method to study the survival of patients before the interventionand the use of the "clock back" estimator for the post-intervention survival in semi-markovian contexts

Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study

Background: Poor attention is paid by recent research to the prevalence of mental well-being in psychiatric patients and the comparison between groups with different diagnoses. Data suggest that the presence of mental illness does not necessarily mean the absence of well-being, particularly in stable outpatients. Methods: A consecutive series of 375 patients attending two community mental health centers was given the Mental Health Continuum Short Form (MHC-SF) and the Clinical Global Impression – Severity scale. Diagnoses were made after the MINI Neuropsychiatric Interview and a chart review of all relevant clinical information. The flourishing category and the three components of MHC-SF were used to rate well-being. A total of 274 controls were taken from the employees at a local firm. Results: The rates of flourishing mental health were: 33.1% schizophrenia, 36.6% bipolar disorder, 23.3% unipolar depression, 24.4% cluster B personality disorder, and 53.3% controls (p < 0.001). The comparison of the three MHC components across diagnostic groups found that unipolar depression and cluster B personality patients had significantly lower scores compared to bipolar and schizophrenia patients. Flourishing mental health was detected more often in males than females (34.9% vs. 24.1% - p < 0.05). For schizophrenia patients indices of well-being were better in those on depot medications. Conclusions: Psychiatric outpatients with major mental illness have lower rates of well-being compared to controls, although about one-third is flourishing. Patients with unipolar depression and cluster B personality disorder may deserve special attention when planning intervention for fostering well-being. Keywords: Well-being, Flourishing, Mental health, Schizophrenia, MHC-SF, Depressio

Ventricular Dyssynchrony: 12-month Evaluation In Ischemic Versus Nonischemic CRT Patients

Objective: Few data exist about the potential differences in the dyssynchrony status of cardiac resynchronization therapy (CRT) candidates stratified by etiology of heart failure, and about the evolution of dyssynchrony at long-term follow-up. We provided a description of intra-ventricular dyssynchrony at baseline, 6 months and 12 months in ischemic and nonischemic CRT patients.Methods: Tissue Doppler Imaging was performed in 35 CRT candidates (18 ischemic, 17 nonischemic) at baseline, and at 6-month and 12-month follow-up. A group of 11 healthy subjects was considered for comparison.Results: At baseline, the standard deviation and the maximum activation delay between any 2 segments were significantly greater in ischemic (38±33ms, 94±76ms) and nonischemic (38±24ms, 96±62ms) patients versus controls (9±7ms, 22±15ms) (all p<0.05). The average time to activation for posterior and lateral wall was significantly higher in nonischemic patients, while the anterior septum activated later in ischemic patients. At 6-month follow-up, standard deviation and maximum delay did not vary in nonischemic while decreased in ischemic group. All changes persisted at 12 months.Conclusions No baseline differences were observed between ischemic and nonischemic patients using studied indices. At 6- and 12-month follow-up, only ischemic patients presented a significant reduction in dyssynchrony values, although in both groups CRT did not lead to a complete normalization of LV synchronism

Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways

Inbreeding is a known risk factor for recessive Mendelian diseases and previous studies have suggested that it could also play a role in complex disorders, such as psychiatric diseases. Recent inbreeding results in the presence of long runs of homozygosity (ROHs) along the genome, which are also defined as autozygosity regions. Genetic variants in these regions have two alleles that are identical by descent, thus increasing the odds of bearing rare recessive deleterious mutations due to a homozygous state. A recent study showed a suggestive enrichment of long ROHs in schizophrenic patients, suggesting that recent inbreeding could play a role in the disease. To better understand the impact of autozygosity on schizophrenia risk, we selected, from a cohort of 180 Italian patients, seven subjects with extremely high numbers of large ROHs that were likely due to recent inbreeding and characterized the mutational landscape within their ROHs using Whole Exome Sequencing and, gene set enrichment analysis. We identified a significant overlap (17%; empirical p-value = 0.0171) between genes inside ROHs affected by low frequency functional homozygous variants (107 genes) and the group of most promising candidate genes mutated in schizophrenia. Moreover, in four patients, we identified novel and extremely rare damaging mutations in the genes involved in neurodevelopment (MEGF8) and in GABA/glutamatergic synaptic transmission (GAD1, FMN1, ANO2). These results provide insights into the contribution of rare recessive mutations and inbreeding as risk factors for schizophrenia. ROHs that are likely due to recent inbreeding harbor a combination of predisposing low-frequency variants and extremely rare variants that have a high impact on pivotal biological pathways implicated in the disease. In addition, this study confirms that focusing on patients with high levels of homozygosity could be a useful prioritization strategy for discovering new high-impact mutations in genetically complex disorders

HIF factors cooperate with PML-RARα to promote acute promyelocytic leukemia progression and relapse

Acute promyelocytic leukemia (APL) is epitomized by the chromosomal translocation t(15;17) and the resulting oncogenic fusion protein PML-RARα. Although acting primarily as a transcriptional repressor, PML-RARα can also exert functions of transcriptional co-activation. Here, we find that PML-RARα stimulates transcription driven by HIF factors, which are critical regulators of adaptive responses to hypoxia and stem cell maintenance. Consistently, HIF-related gene signatures are upregulated in leukemic promyelocytes from APL patients compared to normal promyelocytes. Through in vitro and in vivo studies, we find that PML-RARα exploits a number of HIF-1α-regulated pro-leukemogenic functions that include cell migration, bone marrow (BM) neo-angiogenesis and self-renewal of APL blasts. Furthermore, HIF-1α levels increase upon treatment of APL cells with all-trans retinoic acid (ATRA). As a consequence, inhibiting HIF-1α in APL mouse models delays leukemia progression and exquisitely synergizes with ATRA to eliminate leukemia-initiating cells (LICs)

Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study

BACKGROUND: Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. AIMS: The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS-COV2 infection. METHODS: Retrospective cohort study of patients 65 years of age and older with SARS-CoV 2 infection admitted to two acute geriatric wards and one rehabilitation ward. Delirium symptoms duration was assessed retrospectively with a chart-based validated method. In-hospital mortality was ascertained via medical records. RESULTS: A total of 241 patients were included. The prevalence of delirium on admission was 16%. The median number of days with delirium symptoms was 4 (IQR 2–6.5) vs. 0 (IQR 0–2) in patients with and without delirium on admission. In the multivariable Cox regression model, each day with a delirium symptom in a patient with the same length of stay was associated with a 10% increase in in-hospital mortality (Hazard ratio 1.1, 95% Confidence interval 1.01–1.2; p = 0.03). Other variables associated with increased risk of in-hospital death were age, comorbidity, CPAP, CRP levels and total number of drugs on admission. CONCLUSIONS: The study supports the necessity to establish protocols for the monitoring and management of delirium during emergency conditions to allow an appropriate care for older patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40520-021-01899-8

Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial.

BACKGROUND: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system with a disabling progressive course. Chronic cerebrospinal venous insufficiency (CCSVI) has recently been described as a vascular condition characterized by restricted venous outflow from the brain, mainly due to blockages of the internal jugular and azygos veins. Despite a wide variability among studies, it has been found to be associated with MS. Data from a few small case series suggest possible improvement of the clinical course and quality of life by performing percutaneous balloon angioplasty (PTA) of the stenotic veins.Study design and methodsThis is a multicenter, randomized, parallel group, blinded, sham-controlled trial to assess the efficacy and safety of PTA. Participants with relapsing remitting MS or secondary progressive MS and a sonographic diagnosis of CCSVI will be enrolled after providing their informed consent. Each participant will be centrally randomized to receive catheter venography and PTA or catheter venography and sham PTA. Two primary end points with respect to efficacy at 12 months are (1) a combined end point obtained through the integration of five functional indicators, walking, balance, manual dexterity, bladder control, and visual acuity, objectively measured by instruments; and (2) number of new brain lesions measured by T2-weighted MRI sequences. Secondary end points include annual relapse rate, change in Expanded Disability Status Scale score, proportion of patients with zero, one or two, or more than two relapses; fatigue; anxiety and depression; general cognitive state; memory/attention/calculus; impact of bladder incontinence; and adverse events. Six hundred seventy-nine patients will be recruited. The follow-up is scheduled at 12 months. Patients, treating neurologists, trained outcome assessors, and the statistician in charge of data analysis will be masked to the assigned treatment. DISCUSSION: The study will provide an answer regarding the efficacy of PTA on patients' functional disability in balance, motor, sensory, visual and bladder function, cognitive status, and emotional status, which are meaningful clinical outcomes, beyond investigating the effects on inflammation. In fact, an important part of patients' expectations, sustained and amplified by anecdotal data, has to do precisely with these functional aspects.Trial registrationClinicaltrials.gov NCT01371760